TABLE OF CONTENTS
Chapter 1 Prefix
1.1 Market Scope
1.2 Report Description
1.3 Research Methodology
1.3.1 Primary Research
1.3.2 Secondary Research
1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
2.1 Global Alzheimer’s Disease Treatment Market Year-on-Year Growth, 2020 – 2028 (%)
Chapter 3 Market Outline
3.1 Market Inclination, Trend, Outlook, and Viewpoint
3.2 Market Share Analysis: Company’s Competitive Scenario
3.3 Value Chain Analysis
3.4 Porter’s Five Forces Analysis
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Impact Analysis
3.5.2 Restraints
3.5.2.1 Impact Analysis
3.5.3 Opportunities
Chapter 4 Global Alzheimer’s Disease Treatment Market by Drug Class: Market Size and Forecast, 2019 – 2028
4.1 Overview
4.2 Cholinergic
4.2.1 Current Trend and Analysis
4.2.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.2.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
4.3 Memantine
4.3.1 Current Trend and Analysis
4.3.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.3.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
4.4 Combined Drug
4.4.1 Current Trend and Analysis
4.4.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.4.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
4.5 AChE Inhibitors
4.5.1 Current Trend and Analysis
4.5.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.5.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
4.6 Immunoglobulins
4.6.1 Current Trend and Analysis
4.6.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.6.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
Chapter 5 Global Alzheimer’s Treatment Market by Distribution: Market Size and Forecast, 2019 – 2028
5.1 Overview
5.2 Hospital Pharmacy
5.2.1 Current Trend and Analysis
5.2.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.2.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
5.3 Retail Pharmacy
5.3.1 Current Trend and Analysis
5.3.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.3.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
5.4 Online Sales
5.4.1 Current Trend and Analysis
5.4.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.4.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
Chapter 6 Global Alzheimer’s Treatment Market by Geography: Market Size and Forecast, 2019 - 2028
6.1 Overview
6.1.1 Global Alzheimer’s Treatment Market Year-on-Year Growth, by region 2020 – 2028 (%)
6.2 North America
6.2.1 Current Trend and Analysis
6.2.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.2.3 U.S.
6.2.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.2.3.2 By Drug Class
6.2.3.3 By Distribution
6.2.4 Canada
6.2.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.2.4.2 By Drug Class
6.2.4.3 By Distribution Channel
6.2.5 Mexico
6.2.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.2.5.2 By Drug Class
6.2.5.3 By Distribution Channel
6.3 Europe
6.3.1 Current Trend and Analysis
6.3.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.3 UK
6.3.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.3.2 By Drug Class
6.3.3.3 By Distribution channel
6.3.4 Russia
6.3.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.4.2 By Drug Class
6.3.4.3 By Distribution Channel
6.3.5 France
6.3.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.5.2 By Drug Class
6.3.5.3 By Distribution Channel
6.3.6 Italy
6.3.6.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.6.2 By Drug Class
6.3.6.3 By Distribution Channel
6.3.7 Germany
6.3.7.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.7.2 By Drug Class
6.3.7.3 By Distribution Channel
6.3.8 Rest of Europe
6.3.8.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.8.2 By Drug Class
6.3.8.3 By Distribution Channel
6.4 Asia-Pacific
6.4.1 Current Trend and Analysis
6.4.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.4.3 China
6.4.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.4.3.2 By Drug Class
6.4.3.3 By Distribution Channel
6.4.4 India
6.4.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.4.4.2 By Drug Class
6.4.4.3 By Distribution Channel
6.4.5 Japan
6.4.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.4.5.2 By Drug Class
6.4.5.3 By Distribution Channel
6.4.6 Rest of Asia-Pacific
6.4.6.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.4.6.2 By Drug Class
6.4.6.3 By Distribution Channel
6.5 RoW
6.5.1 Current Trend and Analysis
6.5.2 Market Size and Forecast
6.5.3 South America
6.5.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.5.3.2 By Drug class
6.5.3.3 By Distribution Channel
6.5.4 Middle East
6.5.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.5.4.2 By Drug Class
6.5.4.3 By Distribution channel
6.5.5 Africa
6.5.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.5.5.2 By Drug Class
6.5.5.3 By Distribution channel
Chapter 7 Company Profiles
7.1 Allergan.
7.1.1 Company Overview
7.1.2 Product Portfolio
7.1.3 Business Strategies
7.1.4 Financials
7.1.5 Recent Developments
7.2 Johnson & Johnson Services.
7.2.1 Company Overview
7.2.2 Product Portfolio
7.2.3 Business Strategies
7.2.4 Financials
7.2.5 Recent Developments
7.3 Eisai Co Ltd.
7.3.1 Company Overview
7.3.2 Product Portfolio
7.3.3 Business Strategies
7.3.4 Financials
7.3.5 Recent Developments
7.4 Novartis AG
7.4.1 Company Overview
7.4.2 Product Portfolio
7.4.3 Business Strategies
7.4.4 Financials
7.4.5 Recent Developments
7.5 DAIICHI SANKYO COMPANY.
7.5.1 Company Overview
7.5.2 Product Portfolio
7.5.3 Business Strategies
7.5.4 Financials
7.5.5 Recent Developments
7.6 Eli Lilly and Company.
7.6.1 Company Overview
7.6.2 Product Portfolio
7.6.3 Business Strategies
7.6.4 Financials
7.6.5 Recent Developments
7.7 Merz Pharma.
7.7.1 Company Overview
7.7.2 Product Portfolio
7.7.3 Business Strategies
7.7.4 Financials
7.7.5 Recent Developments
7.8 Pfizer Inc.
7.8.1 Company Overview
7.8.2 Product Portfolio
7.8.3 Business Strategies
7.8.4 Financials
7.8.5 Recent Developments
7.9 H. Lundbeck A/S.
7.9.1 Company Overview
7.9.2 Product Portfolio
7.9.3 Business Strategies
7.9.4 Financials
7.9.5 Recent Developments
7.10 AstraZeneca.
7.10.1 Company Overview
7.10.2 Product Portfolio
7.10.3 Business Strategies
7.10.4 Financials
7.10.5 Recent Developments
7.11 F. Hoffmann-La Roche Ltd.
7.11.1 Company Overview
7.11.2 Product Portfolio
7.11.3 Business Strategies
7.11.4 Financials
7.11.5 Recent Developments
7.12 VTV Therapeutics.
7.12.1 Company Overview
7.12.2 Product Portfolio
7.12.3 Business Strategies
7.12.4 Financials
7.12.5 Recent Developments
7.13 TauRe.
7.13.1 Company Overview
7.13.2 Product Portfolio
7.13.3 Business Strategies
7.13.4 Financials
7.13.5 Recent Developments
7.14 AC Immune.
7.14.1 Company Overview
7.14.2 Product Portfolio
7.14.3 Business Strategies
7.14.4 Financials
7.14.5 Recent Developments
7.15 Teva Pharmaceutical Industries Ltd.
7.15.1 Company Overview
7.15.2 Product Portfolio
7.15.3 Business Strategies
7.15.4 Financials
7.15.5 Recent Developments
7.16 AB Science.
7.16.1 Company Overview
7.16.2 Product Portfolio
7.16.3 Business Strategies
7.16.4 Financials
7.16.5 Recent Developments
7.17 Bristol-Myers Squibb Company.
7.17.1 Company Overview
7.17.2 Product Portfolio
7.17.3 Business Strategies
7.17.4 Financials
7.17.5 Recent Developments
7.18 ONO PHARMACEUTICAL CO LTD.
7.18.1 Company Overview
7.18.2 Product Portfolio
7.18.3 Business Strategies
7.18.4 Financials
7.18.5 Recent Developments
7.19 Takeda Pharmaceutical Company Limited
7.19.1 Company Overview
7.19.2 Product Portfolio
7.19.3 Business Strategies
7.19.4 Financials
7.19.5 Recent Developments
7.20 GENERAL ELECTRIC.
7.20.1 Company Overview
7.20.2 Product Portfolio
7.20.3 Business Strategies
7.20.4 Financials
7.20.5 Recent Develop
Payment Options